Ophthalmology-focused pharmaceutical compounding business ImprimisRx has entered into a product supply agreement with iOR Partners.
iOR Partners specializes in office-based cataract surgery in ophthalmic practices. Through the agreement, ImprimisRx will provide supplies for outpatient surgeries. Physicians at iOR Partners are expected to complete 45,000 surgeries this year.
"In-office surgery is likely where the ophthalmic surgery market is headed, so we’re pleased to provide iOR with the pharmaceutical formulations needed to continue the impressive progress they’re making as they help lead our industry forward," said John Saharek, president of ImprimisRx.